The WHO estimates the average medication adherence rate is 50% in developed nations, though the U.S. trails other countries in reported adherence on Medisafe.…

Amgen

Don’t get too excited about U.S. corporate tax reform, pharma. It may not all be pretty

Regeneron CEO: Amgen's disruptive Praluent-blocking patent move hurts patients

Sanofi and Regeneron ordered to halt Praluent sales, but companies to appeal judge's decision

Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling

It's the same song, but a brand-new verse for 2017's drug-pricing debate

With billions at stake, will biosims finally make a mark in the U.S. in 2017?

Payers may see biosims as a no-brainer, but marketing them won't be